Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Konrad Aden

Proferssor of Gastroenterology and Metabolomics

Kiel University

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (20)

Collaborators (3)

Christoph Kaleta

Professor of Medical Systems Biology

Christian-Albrechts-Universität zu Kiel

Philip Rosenstiel

Kiel University

Johannes Zimmermann

Junior Group Leader

Friedrich Schiller University Jena

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Konrad Aden

Research Interests

Make your next move.

Explore related searches

Articles (20)

Collaborators (3)

Christoph Kaleta

Philip Rosenstiel

Johannes Zimmermann

Make your next move.

Konrad Aden

Research Interests

Make your next move.

Explore related searches

Articles (20)

Systematic Screening of Tryptophan Metabolism Identifies Site- and Microbiota-Dependent Signatures of Tryptophan Utilization in Experimental Colitis

Rise of precision medicine: can it deliver on its promise in IBD?

<i>Escherichia-Shigella</i> expansion and metabolite dysregulation in type 3c diabetes: linking microbiome alterations to exocrine pancreatic insufficiency

A metabolic constraint in de novo NAD<SUP>+</SUP> synthesis drives mucosal inflammation in IBD

Biomarker-informed therapy guidance improved clinical outcomes of anti-tumour necrosis factor treatment in patients with inflammatory bowel disease in a multi-centre, randomized, controlled, open-label, prospective clinical trial (GUIDE-IBD)

Bowel urgency across inflammatory bowel disease phenotypes: A large real-world analysis reveals high symptom burden in ileal Crohn's disease

Defining comprehensive disease control in ulcerative colitis through a molecular remission score derived from mucosal transcriptomic and microbial signatures

Evaluating liver fibrosis risk in patients with Inflammatory Bowel Disease: Limitations of the Fibrosis-4 score

Fecal Detection of Calprotectin Subunits Links Inflammatory Bowel Disease Activity With Chronicity of Intestinal Inflammation

Identification of molecular hallmarks of Inflammatory Bowel Disease presenting with arthropathic comorbidities

Intestinal Fibroblast-specific QPRT Deficiency Disrupts Epithelial Homeostasis via Mitochondrial-Driven Inflammation

Longitudinal metagenomic profiling reveals early microbial changes during infliximab response in IBD.

Single-cell longitudinal profiling of peripheral blood identifies shared and therapy-specific immune signatures of early remission in ulcerative colitis

Systematic screening of tryptophan metabolism identifies site- and microbial-specific signatures of tryptophan utilization in experimental colitis

Type I and II interferon blood signatures correlate with ultrasound markers of intestinal fibrostenosis and predict surgical outcomes in Crohn's disease

Microbiota-derived metabolites in inflammatory bowel disease

Author Correction: Metabolic modeling reveals a multi-level deregulation of host-microbiome metabolic networks in IBD

How “Sure” Are We About Precision Medicine in IBD?

A distinct serum metabolic signature outperforms C-reactive protein as a non-invasive marker for monitoring disease activity in Inflammatory Bowel Disease

A multi-omics approach across multiple chronic inflammatory diseases identifies a distinct type-1-interferon endotype of Inflammatory Bowel Disease

Collaborators (3)

Christoph Kaleta

Philip Rosenstiel

Johannes Zimmermann

Make your next move.